Biomedicine

Spectral reports second quarter results

Published in Lab Law Weekly, August 24th, 2007

Spectral Diagnostics Inc. ("Spectral") reported a loss of $379,000 (1 cent per share) for the quarter ended June 30, 2007 compared to net income of $4,751,000 (23 cents per share) for the same period last year. The prior period earnings included a one time gain of $5,444,000 (27 cents per share) on the settlement of certain convertible notes payable.

For the six months ended June 30, 2007, the Company recorded a loss of $586,000 (2 cents per share), compared to net income of $5,138,000 (26 cents per share) last year. In addition to the aforementioned gain on settlement of convertible notes payable, last year's six month net income also included a gain of $2,385,000 (12...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Law Weekly

Source: Lab Law Weekly (2007-08-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry